Versartis Trial in Children to Assess Long-Acting Growth Hormone

Clinical trial NCT01718041 · COMPLETED

Trial details

NCT number: NCT01718041
Sponsor: Versartis Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pediatric Growth Hormone Deficiency

Start date: 2012-10-01
Primary completion: 2014-07-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.